NCT02594111View on ClinicalTrials.gov

Colchicine in Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL
Enrollment

714

Participants

Timeline

Start Date

May 30, 2013

Primary Completion Date

August 30, 2019

Study Completion Date

December 31, 2021

Conditions
Coronary Artery DiseaseAcute Coronary Syndrome
Interventions
DRUG

Colchicine vs Placebo

Colchicine vs Placebo 1.8 mg PO over 1 hour

Trial Locations (1)

10010

Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York

All Listed Sponsors
collaborator

NYU Langone Health

OTHER

lead

VA Office of Research and Development

FED

NCT02594111 - Colchicine in Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter